RLMD Relmada Therapeutics, Inc.

Fundamentals / CIK 0001553643 / USD

Relmada Therapeutics, Inc. reported $205.3M in total assets and a net loss of $65.70M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open RLMD in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2017 to 2025), reported in USD.

$0$0$0-$146.8MFY 2017 Net Income: -$6.29M2017FY 2018 Net Income: -$8.96M2018FY 2019 Net Income: -$17.32M2019FY 2019 Net Income: -$15.01M2019FY 2020 Net Income: -$59.46M2020FY 2021 Net Income: -$125.8M2021FY 2022 Net Income: -$157.0M2022FY 2023 Net Income: -$98.79M2023FY 2024 Net Income: -$79.98M2024FY 2025 Net Income: -$57.39M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Jun 30 Jun 30 Jun 30
Research & Development $26.88M $46.18M $54.81M $113.3M $90.62M $35.97M $7.86M $7.02M $2.94M $1.29M
Total Operating Expenses $59.10M $83.89M $103.7M $161.2M $125.7M $60.84M $15.11M $12.73M $6.92M $7.22M
Operating Income -$59.10M -$83.89M -$103.7M -$161.2M -$125.7M -$60.84M -$15.11M -$12.73M -$6.92M -$7.22M
EBITDA -- -- -- -- -$125.7M -$60.83M -$15.10M -$12.72M -$6.91M -$7.13M
Interest Income $1.40M $3.53M $5.15M -- -- -- -- -- -- --
Net Income -$57.39M -$79.98M -$98.79M -$157.0M -$125.8M -$59.46M -$15.01M -$17.32M -$8.96M -$6.29M
Basic EPS -$1.45 -$2.65 -$3.28 -$5.30 -$7.16 -$3.81 -$1.62 -$2.74 -$0.71 -$0.52
Diluted EPS -$1.45 -$2.65 -$3.28 -$5.30 -$7.16 -$3.81 -$1.62 -$2.74 -$0.71 -$0.52
Basic Shares Outstanding 39.5M 30.2M 30.1M 29.6M 17.6M 15.6M 9.2M 6.3M 12.5M 12.1M
Diluted Shares Outstanding 39.5M 30.2M 30.1M 29.6M 17.6M 15.6M 9.2M 6.3M 12.5M 12.1M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $9.22M $8.39M $8.09M $8.07M $4.04M $2.82M $11.95M $11.00M
Total Operating Expenses $13.10M $15.01M $19.46M $20.33M $10.33M $10.22M $18.22M $19.08M
Operating Income -$13.10M -$15.01M -$19.46M -$20.33M -$10.33M -$10.22M -$18.22M -$19.08M
Interest Income $2.27M $2.30M $960K $387K $247K $321K $440K $655K
Net Income -$13.86M -$12.91M -$19.05M -$19.87M -$10.09M -$9.87M -$17.56M -$18.66M
Basic EPS -$0.12 -$0.11 -$0.22 -- -$0.30 -$0.30 -$0.58 --
Diluted EPS -$0.12 -$0.11 -$0.22 -- -$0.30 -$0.30 -$0.58 --
Basic Shares Outstanding 112.4M 112.4M 86.6M -- 33.2M 33.2M 30.4M --
Diluted Shares Outstanding 112.4M 112.4M 86.6M -- 33.2M 33.2M 30.4M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Jun 30 Jun 30 Jun 30
Cash & Cash Equivalents $3.50M $3.86M $4.09M $5.40M $44.44M $2.50M $36.28M $9.22M $2.24M $1.71M
Short-Term Investments $89.51M $41.05M $92.23M $142.9M $167.5M $114.6M $80.16M -- -- --
Cash & Short-Term Investments $93.01M $44.91M $96.32M $148.3M $211.9M $117.1M $116.4M $9.22M $2.24M $1.71M
Accounts Receivable, Net -- -- -- $512K -- -- -- -- -- --
Total Current Assets $93.98M $45.80M $97.51M $152.9M $223.3M $118.1M $116.9M $9.98M $2.74M $2.47M
Property, Plant & Equipment, Net -- -- -- -- -- $1.3K $5.0K $7.2K $12K $2.3K
Other Non-Current Assets $20K $22K $43K $35K $28K $25K $25K $25K $25K $22K
Total Non-Current Assets $20K $22K $43K $35K $28K $113K $196K $235K $310K $362K
Total Assets $94.00M $45.82M $97.55M $152.9M $223.3M $118.2M $117.1M $10.22M $3.05M $2.84M
Accounts Payable $1.57M $4.13M $3.51M $5.26M $11.19M $8.35M $523K $924K $765K $530K
Total Current Liabilities $6.43M $10.29M $12.19M $12.47M $15.06M $12.60M $1.46M $2.61M $5.90M $1.38M
Total Non-Current Liabilities $1.06M $4.5K $0 $0 $0 $0 $0 $0 $2.66M $0
Total Liabilities $7.49M $10.30M $12.19M $12.47M $15.06M $12.60M $1.46M $2.61M $8.56M $1.38M
Common Stock $73K $30K $30K $30K $28K $16K $14K $9.7K $13K $13K
Retained Earnings -$698.3M -$640.9M -$560.9M -$462.1M -$305.1M -$179.3M -$119.9M -$111.7M -$94.34M -$85.38M
Total Stockholders' Equity $86.51M $35.52M $85.36M $140.4M $208.3M $105.6M $115.7M $7.61M -$5.51M $1.46M
Total Equity $86.51M $35.52M $85.36M $140.4M $208.3M $105.6M $115.7M $7.61M -$5.51M $1.46M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $5.72M $11.33M $9.78M $3.50M $1.38M $1.35M $1.15M $3.86M
Short-Term Investments $196.4M $206.4M $224.2M $89.51M $12.50M $19.27M $25.91M $41.05M
Cash & Short-Term Investments $202.1M $217.7M $234.0M $93.01M $13.89M $20.62M $27.06M $44.91M
Total Current Assets $205.0M $219.0M $235.3M $93.98M $14.85M $21.09M $27.66M $45.80M
Other Non-Current Assets $247K $20K $20K $20K $22K $22K $22K $22K
Total Non-Current Assets $247K $20K $20K $20K $22K $22K $22K $22K
Total Assets $205.3M $219.1M $235.4M $94.00M $14.88M $21.12M $27.68M $45.82M
Accounts Payable $2.54M $2.41M $5.73M $1.57M $1.45M $1.36M $1.27M $4.13M
Total Current Liabilities $7.78M $7.42M $12.89M $6.43M $5.19M $5.13M $5.23M $10.29M
Total Non-Current Liabilities $3.78M $5.08M $3.74M $1.06M $221K $32K $7.5K $4.5K
Total Liabilities $11.56M $12.50M $16.63M $7.49M $5.41M $5.17M $5.24M $10.30M
Common Stock $107K $107K $105K $73K $33K $33K $33K $30K
Retained Earnings -$744.1M -$730.2M -$717.3M -$698.3M -$678.4M -$668.3M -$658.4M -$640.9M
Total Stockholders' Equity $193.7M $206.6M $218.7M $86.51M $9.47M $15.95M $22.44M $35.52M
Total Equity $193.7M $206.6M $218.7M $86.51M $9.47M $15.95M $22.44M $35.52M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Jun 30 Jun 30 Jun 30
Net Income -$57.39M -$79.98M -$98.79M -$157.0M -$125.8M -$59.46M -$15.01M -$17.32M -$8.96M -$6.29M
Depreciation & Amortization -- -- -- -- $1.3K $3.8K $4.4K $4.9K $2.6K $85K
Stock-Based Compensation $13.91M $30.18M $43.81M $44.19M $40.49M $20.78M $3.17M $1.21M $518K $704K
Change in Receivables -- -- -- -$512K -- -- -- -- -- --
Change in Payables -$2.56M $625K -$1.76M $421K $2.85M $7.82M $164K $159K $157K -$730K
Operating Cash Flow -$45.79M -$51.76M -$51.66M -$103.8M -$91.87M -$27.81M -$12.09M -$10.50M -$6.00M -$6.47M
Capital Expenditure -- -- -- -- -- -$182.1M -$84.85M -- -$12K -$50K
Free Cash Flow -- -- -- -- -- -$209.9M -$96.94M -- -$6.01M -$6.52M
Purchases of Investments -- -- -- -$47.29M -$223.0M -$182.1M -- -- -- --
Investing Cash Flow -$48.14M $51.56M $50.45M $19.73M -$54.12M -$34.45M -$80.16M -- -$12K -$50K
Common Stock Issued $93.64M -- -- $42.73M $184.6M $19.79M -- $17.84M -- --
Financing Cash Flow $93.56M -$40K -$98K $45.02M $187.9M $28.47M $126.1M $17.48M $6.54M -$274K
Net Change in Cash -$360K -$235K -$1.30M -$39.05M $41.95M -$33.78M $33.85M $6.98M $528K -$6.79M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$13.86M -$12.91M -$19.05M -$19.87M -$10.09M -$9.87M -$17.56M -$18.66M
Stock-Based Compensation $1.02M $903K $956K $3.28M $3.61M $3.45M $3.57M $6.73M
Change in Payables $129K -$922K $1.76M $116K $91K $97K -$2.87M $1.79M
Operating Cash Flow -$12.59M -$9.61M -$15.07M -$14.60M -$6.72M -$6.40M -$18.07M -$8.80M
Investing Cash Flow $6.95M $17.59M -$135.2M -$76.93M $6.75M $6.68M $15.36M $11.35M
Share Repurchases $0 -$6.46M -$3.36M -- -- -- -- --
Financing Cash Flow $18K -$6.42M $156.6M -- -- -- -- -$172K
Net Change in Cash -$5.61M $1.56M $6.28M $2.11M $31K $204K -$2.71M $2.37M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Jun 30 Jun 30 Jun 30
Return on Equity (ROE) -66.3% -225.2% -115.7% -111.8% -60.4% -56.3% -13.0% -227.5% -- -430.5%
Return on Assets (ROA) -61.0% -174.6% -101.3% -102.7% -56.3% -50.3% -12.8% -169.5% -294.0% -221.6%
Current Ratio 14.62x 4.45x 8.00x 12.26x 14.83x 9.37x 80.21x 3.83x 0.46x 1.80x
Quick Ratio 14.46x 4.36x 7.90x 11.94x 14.07x 9.29x 79.87x 3.54x 0.38x 1.24x

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -33.9% -30.0% -26.9% -66.3% -593.5% -425.1% -337.4% -225.2%
Return on Assets (ROA) -32.0% -28.3% -25.0% -61.0% -377.6% -321.1% -273.5% -174.6%
Current Ratio 26.37x 29.52x 18.26x 14.62x 2.86x 4.11x 5.29x 4.45x
Quick Ratio 25.99x 29.34x 18.15x 14.46x 2.68x 4.02x 5.17x 4.36x
Source: SEC EDGAR CompanyFacts (CIK 0001553643) · from August 31, 2011 Data through September 30, 2026 · synced Nov 20, 2026, 05:37 UTC · Open in terminal